Efficacy of Dead Sea Peloid Gel in Chronic Endometritis

Efficacy of Intravaginal Dead Sea Peloid Gel Administration in Complex Treatment of Chronic Endometritis and Reproductive Disorders: Randomized Placebo-controlled Prospective Study

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02680275

Enrollment

Registered

2016-02-11

Start date

2011-07-31

Completion date

2013-06-30

Last updated

2016-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Endometritis

Keywords

Chronic endometritis, Miscarriage, Infertility

Brief summary

This study evaluates the effect of Dead Sea Peloid Gel in the treatment of Chronic Endometritis in women with reproductive disorders. Half of participants will receive Dead Sea Peloid Gel and antibiotics, while the other half will receive Placebo Gel and antibiotics. Patients with reproductive disorders who visited Research Medical Center of Family Health Problems and Human Reproduction were recruited.

Detailed description

Dead Sea Peloid Gel achieves improvement of blood circulation and receptor sensitivity of endometrium.

Interventions

DRUGDead Sea Peloid Gel

intravaginally

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Inclusion criteria

* Women with miscarriage associated with chronic endometritis * Women without mental disorders able to swallow tablets

Exclusion criteria

Clinical diagnosis of: * sexually transmitted diseases * endometrium hyperplasia and/or polyps * uterina fibroids * endocrine disorders * trombophilia

Design outcomes

Primary

Measure	Time frame
The prevalence of spontaneous pregnancy the first year after treatment	during first year

Secondary

Measure	Time frame
The prevalence of women with morphological status of chronic endometritis by the 3 months after treatment.	during 3 months

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026